Dymon Asia Capital (Singapore)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65M Buy
18,300
+3,900
+27% +$909K 0.19% 70
2026
Q1
$3.52M Buy
14,400
+9,450
+191% +$2.2M 0.36% 81
2025
Q4
$1.02M Sell
4,950
-7,050
-59% -$1.39M 0.1% 163
2025
Q3
$2.23M Sell
12,000
-2,000
-14% -$343K 0.23% 89
2025
Q2
$2.14M Buy
+14,000
New +$2.15M 0.3% 71
2021
Q1
Sell
-1,683
Closed -$265K 159
2020
Q4
$265K Buy
+1,683
New +$248K 0.06% 103

Other funds holding JNJ

Dymon Asia Capital (Singapore)'s JNJ Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, buying an estimated $909K and bringing the position to 18,300 shares worth $4.65M. The position accounts for 0.19% of the portfolio, ranked #70.

Dymon Asia Capital (Singapore) first reported a position in JNJ in Q4 2020 and has held it in 6 quarters since. 2,503 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 18,300 shares of Johnson & Johnson worth $4.65M as of Q2 2026.
  • Dymon Asia Capital (Singapore) bought 3,900 Johnson & Johnson shares in Q2 2026, an estimated $909K.
  • Johnson & Johnson made up 0.19% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #70 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Johnson & Johnson in Q4 2020 and has held it in 6 quarters since.
  • 2,503 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.